Risk for Reduced Bone Mineral Density in Patients With Ulcerative Colitis
A potential association was found between ulcerative colitis and decreased bone mineral density, regardless of steroid exposure.
A potential association was found between ulcerative colitis and decreased bone mineral density, regardless of steroid exposure.
Researchers have found that tofacitinib, a drug approved by the FDA to treat rheumatoid arthritis and ulcerative colitis, might also treat leaky gut.
A recently published report presented at the 2019 AIBD Annual Meeting in Orlando, FL, discussed the case of a patient who developed ulcerative colitis (UC) following treatment with Secukinumab for her psoriatic arthritis and highlighted a novel approach for the management of both of her conditions simultaneously.
Cyltezo subcutaneous injection has been approved by the FDA.